Biotech Stocks Facing FDA Decision In September

1 / 10

It’s that time again to take a look at the biotech companies whose drug candidates are at the FDA altar, waiting for approval.

So far this year, 16 novel drugs have secured FDA approval.

Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.